- Pharming press release (NASDAQ:PHAR) (OTCPK:PHGUF): Q2 GAAP EPS of $0.006.
- Revenue of $93.2M (+25.8% Y/Y).
- Full-year 2025 total revenue guidance raised to $335 million - $350 million, up from prior $325 million - $340 million.
- Overall cash and marketable securities